Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (330)
  • News item (238)
  • Subject (31)
  • Blog post (7)
  • Activity (5)
  • Single page (3)

Publication date

Selecting an option will change the focus to the start of the list.
  • June 2026 (5)
  • May 2026 (3)
  • April 2026 (1)
  • March 2026 (7)
  • February 2026 (4)
  • January 2026 (1)
  • December 2025 (5)
  • November 2025 (6)
  • October 2025 (9)
  • September 2025 (7)
  • August 2025 (5)
  • July 2025 (2)
  • June 2025 (8)
  • May 2025 (3)
  • April 2025 (3)
  • March 2025 (2)
  • February 2025 (4)
  • January 2025 (6)
  • December 2024 (6)
  • November 2024 (4)
  • October 2024 (5)
  • September 2024 (2)
  • August 2024 (3)
  • July 2024 (4)
  • June 2024 (6)
  • May 2024 (9)
  • April 2024 (11)
  • March 2024 (5)
  • February 2024 (4)
  • December 2023 (11)
  • November 2023 (2)
  • October 2023 (3)
  • September 2023 (9)
  • August 2023 (1)
  • July 2023 (8)
  • June 2023 (4)
  • May 2023 (6)
  • April 2023 (11)
  • March 2023 (10)
  • February 2023 (8)
  • January 2023 (1)
  • December 2022 (5)
  • November 2022 (14)
  • October 2022 (10)
  • September 2022 (4)
  • August 2022 (3)
  • July 2022 (8)
  • June 2022 (1)
  • May 2022 (6)
  • April 2022 (3)
  • March 2022 (5)
  • February 2022 (6)
  • January 2022 (8)
  • December 2021 (38)
  • November 2021 (9)
  • October 2021 (3)
  • September 2021 (8)
  • August 2021 (6)
  • July 2021 (6)
  • June 2021 (26)
  • May 2021 (19)
  • April 2021 (15)
  • March 2021 (10)
  • February 2021 (9)
  • January 2021 (5)
  • December 2020 (6)
  • November 2020 (3)
  • September 2020 (5)
  • July 2020 (5)
  • June 2020 (7)
  • May 2020 (8)
  • April 2020 (4)
  • March 2020 (8)
  • February 2020 (3)
  • January 2020 (6)
  • December 2019 (3)
  • November 2019 (3)
  • October 2019 (4)
  • September 2019 (2)
  • August 2019 (3)
  • July 2019 (2)
  • June 2019 (2)
  • May 2019 (4)
  • April 2019 (2)
  • March 2019 (2)
  • February 2019 (5)
  • January 2019 (3)
  • December 2018 (3)
  • November 2018 (11)
  • October 2018 (1)
  • August 2018 (1)
  • July 2018 (1)
  • May 2018 (1)
  • April 2018 (1)
  • February 2018 (3)
  • December 2017 (5)
  • November 2017 (3)
  • October 2017 (1)
  • September 2017 (3)
  • August 2017 (1)
  • May 2017 (1)
  • December 2016 (1)
  • October 2016 (1)
  • March 2016 (2)
  • January 2016 (1)
  • November 2015 (1)
  • July 2015 (2)
  • June 2015 (1)
  • April 2015 (2)
  • March 2015 (1)
  • January 2015 (4)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (1)
  • February 2014 (2)
  • December 2013 (2)
  • November 2013 (1)
  • August 2013 (1)
  • July 2013 (1)
  • May 2013 (2)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (1)
  • July 2012 (2)
  • March 2012 (1)
  • February 2012 (1)
  • January 2012 (5)
  • December 2011 (1)
  • November 2011 (12)
  • September 2011 (1)
  • August 2011 (1)
  • March 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • COVID-19 (76)
  • International (63)
  • Health research for COVID-19 (37)
  • International projects (19)
  • Behavioural science (18)
  • Dutch Food Composition Database (NEVO) (16)
  • RIVM (14)
  • Food and Nutrition (11)
  • Dutch National Food Consumption Survey (9)
  • Mental Health (9)
  • Nanotechnology and advanced materials (9)
  • Respiratory infections (9)
  • Tick bites (8)
  • Sexually transmitted infections (STIs) (7)
  • Tobacco (7)
  • Wastewater research (7)
  • National Immunisation Programme (6)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (6)
  • Flu and flu vaccine (5)
  • Food safety (5)
  • Immunisation and vaccination (5)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (5)
  • Zoonotic diseases (5)
  • Antimicrobial resistance (4)
  • ConsExpo (4)
  • Consumer exposure to chemical substances (4)
  • Ebola (4)
  • Population screening programs in the Caribbean Netherlands (4)
  • WHO Collaborating Centre for Nutrition (4)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (4)
  • Breast Cancer Screening Programme (3)
  • Dengue (3)
  • Gonorrhoea (3)
  • Heat (3)
  • HPV (3)
  • Infectious Disease Control (3)
  • Livestock farming and health (3)
  • Lyme disease (3)
  • Mosquitos (3)
  • Occupational Safety (3)
  • One Health (3)
  • Physical Activity (3)
  • Plastics (3)
  • Public Health Foresight (3)
  • Public Health Monitors (3)
  • Respiratory syncytial virus (RSV) (3)
  • Alternatives to animal testing (2)
  • Cervical cancer screening programme (2)
  • Chikungunya (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Malaria (2)
  • Marburg virus disease (2)
  • Measles (2)
  • Medical devices (2)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (2)
  • Mpox (2)
  • Nitrogen (2)
  • Population screening programmes (2)
  • Scabies (2)
  • West Nile fever (2)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (2)
  • Whooping cough (2)
  • Bird flu (avian influenza) (1)
  • Bisphenol A (BPA) (1)
  • Chickenpox (1)
  • Circular economy (1)
  • Contact (1)
  • Coronaviruses (1)
  • DNA and public health (1)
  • Global Health Security (1)
  • Hantavirus (1)
  • Health promotion (1)
  • Hepatitis B (1)
  • Incidents and disasters (1)
  • International Health Information (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Medicinal products (1)
  • Meningococcal disease (1)
  • MERS (1)
  • Newborn hearing screening (1)
  • One Health (1)
  • Perinatal screening (1)
  • PFAS (1)
  • Pneumococci (1)
  • Probit functions (1)
  • Rotavirus (1)
  • Rubber granulate (1)
  • Shigellosis (1)
  • Soil and water (1)
  • SPADE (1)
  • Sustainable Development Goals (1)
  • Sustainable procurement (1)
  • Tick-borne encephalitis (1)
  • Tuberculosis (1)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (1)
  • WHO Collaborating Centre on Chemical Food Safety (1)
  • Zika Virus (1)

625 search results

You searched for these word(s): VISIT buyfishscalecocaine.com BUY COCAINE POWDER ONLINE
  • Issue 17

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/17

    … Communication resources for various targets groups … specific target group based on national and international recommendations. Since we want to vaccinate as many people as … be vaccinated? When can this take place? It is now recommended that pregnant women be routinely vaccinated, when …

    Publication date: 05-10-2021
  • Newsletter on COVID-19 vaccination issue 8 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/8

    … Public communication … Upcoming events … older people living at home have been on the rise again compared to two weeks ago. The continued significant … nausea and vomiting may also occur after vaccination with Comirnaty (Pfizer/BioNTech), Moderna and AstraZeneca … (in number and severity) in response to the mRNA vaccines (Comirnaty and Moderna). The AstraZeneca vaccine can also …

    Publication date: 03-01-2021
  • Issue 33

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/33

    … Public communication … who have an allergic reaction to the COVID-19 vaccine or a component of the vaccine have a provisional contraindication … for vaccination. This option replaces the previous recommendation not to vaccinate in the event of an allergic … Evaluation starts for use of COVID-19 vaccine Comirnaty (Pfizer) in children aged 5 to 11 years The …

    Publication date: 10-26-2021
  • Newsletter on COVID-19 vaccination issue 5 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/5

    … Medicines Agency (EMA) issued a positive scientific recommendation for the third COVID-19 vaccine in the European … with the University of Oxford. That same day, the European Commission announced that it had approved the vaccine for … strategy as it is currently planned.   Interval for Comirnaty® (Pfizer/BioNTech) The Health Council of the …

    Publication date: 02-11-2021
  • Issue 25

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/25

    … Public communication … states that an interval of at least 21 days is used for Comirnaty® (Pfizer/BioNTech) and 28 days for Spikevax® … available at the Municipal Public Health Services (GGDs). A communication from GGD GHOR Netherlands will provide more … have a second vaccination with the Pfizer/BioNTech vaccine (Comirnaty®), can make an appointment for vaccination by the …

    Publication date: 07-19-2021
  • Newsletter on COVID-19 vaccination issue 6 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/6

    … Comparison with other countries … Public communication … Upcoming events … Situation Dashboard shows the progress in the Netherlands compared to other countries: After a slightly later start, … define the group of people with a neurological condition in combination with respiratory problems. This round of …

    Publication date: 02-16-2021
  • Help

    https://www.rivm.nl/en/consexpo/related-tools/dustex-tool/help

    … air and subsequently transported into different indoor compartments airborne particles, indoor surfaces and dust. … considers all pathways and will therefore enable a more complete assessment of exposure, reducing the probability of … exposure. Information and suggested input can be accessed online using the ? buttons next to the parameter input …

    Publication date: 05-16-2017
  • Issue 32

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/32

    … Public communication … for an extra dose (third jab) or booster dose. Read the recommendations of EMA’s human medicines committee , and the subsequent recommendations of the Medicines Evaluation Board (CBG-MEB) . … COVID-19 vaccination in combination with other vaccinations  Do you have an …

    Publication date: 10-13-2021
  • Newsletter on COVID-19 vaccination issue 4 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/4

    … Public communication … Upcoming events … so they must be kept in stock at the location. It is recommended to vaccinate with a longer needle (38 mm) if: 1. … the skin fold, a longer needle is needed. Note: If someone comes in for the 2nd vaccination, and turns out to need a …

    Publication date: 01-29-2021
  • Issue 31

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/31

    … Upcoming events … pulse therapy and high-dose oral); Mycophenolate mofetil in combination with one or more other immunosuppressants.  * If … More information is available on the page on immunocompromised patients .   … The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) is …

    Publication date: 09-30-2021
  • Issue 18

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/18

    … vial using Vernacare needle and SJJ needle-syringe combination … Public communication … municipalities, Municipal Public Health Services (GGDs) and communities are making an extra effort to reach and provide … data. It therefore advises following the interval recommended in the product information: between 4 and 12 …

    Publication date: 05-25-2021
  • Issue 24

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/24

    … Public communication … tiredness, chills, headaches and muscle aches after the combination of two different vaccines. The practical effects … and safety of heterologous vaccination with other vaccine combinations. … with the BioNTech/Pfizer vaccine is the only approved combination; other vaccine combinations are not possible, …

    Publication date: 07-15-2021
  • Newsletter Microplastics December 2020

    https://www.rivm.nl/en/microplastics/newsletter-microplastics-december-2020

    … bag or drink bottle that ends up in the environment decomposes.   Despite the current focus on plastics and … campaign. The researchers in question looked at three common plastics: polyethylene, polypropylene and … This will tell us what plastics, in what quantities, come into and leave the Netherlands via the rivers.   Too …

    Publication date: 12-03-2020
  • Issue 20

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/20

    … Convenient overview of syringe and needle combinations … Public communication … of May 2021, the COVID-19 vaccine made by Pfizer/BioNTech (Comirnaty®) was the first to receive a positive recommendation from the European Medicines Agency for children … The Health Council has recommended using mRNA vaccines (Pfizer/BioNTech and Moderna) …

    Publication date: 06-17-2021
  • Issue 27

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/27

    … Public communication … sailing under the Dutch flag or for a Dutch shipping company. Expected route for patients with severe allergic … will be delivered for adding NaCl to the Pfizer vaccine (Comirnaty). This syringe is a replacement for the BD 3 ml … will be delivered for adding NaCl to the Pfizer vaccine (Comirnaty). This syringe is a replacement for the BD 3 ml …

    Publication date: 08-10-2021
  • Archive COVID-19 updates 2021

    https://www.rivm.nl/en/novel-coronavirus-covid-19/archive-covid-19-updates-2021

    … least one vaccination in the basic series, and 85.9% have completed the basic series. It is estimated that 87.3% of … least one vaccination in the basic series, and 84.3% have completed the basic series.  Read more about  COVID-19 … also be used in the event of mild symptoms and prior to a visit. People who test positive using a self-test are …

    Publication date: 01-10-2022
  • Articles Environment and Safety 2022

    https://www.rivm.nl/en/about-rivm/corporate-publications/scientific-report/articles-environment-and-safety-2022

    … Geophys Res Atmos 2022; 127(9):e2021JD035687 Open Access A comparative biodistribution study of polymeric and … Open Access A Tiered Approach for Assessing Individual and Combined Risk of Pyrethroids Using Human Biomonitoring Data … 2022; 319:115598 Open Access ZZS similarity tool: The online tool for similarity screening to identify chemicals …

    Publication date: 06-26-2023
  • Publications on tobacco and nicotine products

    https://www.rivm.nl/en/tobacco/publications-on-tobacco-and-related-products

    … functionality. Towards a nicotine-free generation 2024 A comparison between the WHO Intense method and the ISO method … van maximale nicotine-emissie advieswaarden  (Dutch) 2025 Recommended Dutch list of prohibited additives in tobacco … 2012 Report and regulation of tobacco ingredients : A comparison of The Netherlands with other countries  (Dutch …

    Publication date: 03-21-2023
  • Archive COVID-19 updates 2020

    https://www.rivm.nl/en/novel-coronavirus-covid-19/archive-covid-19-updates

    … they died. Not everyone who tests positive for COVID-19 becomes so ill that they have to be hospitalised. Many people … COVID-19 as patients. This term has now been updated in our communications. 8-12-2020 | 19:25 PM Effect on reproduction … they died. Not everyone who tests positive for COVID-19 becomes so ill that they have to be hospitalised. Many people …

    Publication date: 09-22-2020
  • Health Check April 2022

    https://www.rivm.nl/en/documenten/health-check-april-2022

    … Ask your customer or visitor these questions. If they answer 'yes ' to one of …

    Publication date: 04-26-2022

Pagination

  • « First
  • ‹ Previous
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Current page 31
  • Page 32
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon